SODIUM BICARBONATE 8.4% VIAL

What it is

SODIUM BICARBONATE 8.4% VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “sodium bicarbonate” and “sodium bicarbonate injection,”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “injection, solution” and “solution” and its route as intravenous.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Hospira, Inc., Exela Pharma Sciences, LLC and Fresenius Kabi USA, LLC.

FDA’s Established Pharmacologic Class for it is Osmotic Laxative.

The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 12 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $7.70 – $7.93 for 50 mL, depending on the NDC ($0.154 to $0.15869 per ML), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-07-22 and 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of 9 of these 13 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-07-22, 2026-08-12. The file is new; the price is not.

What NADAC measures · NADAC explanation codes · Carried-forward prices

The 8 labelers

When these prices took effect

• 2026-09-23 · 4 NDCs · $0.15869 per ML filed
• 2026-08-12 · 1 NDC, carried forward from an earlier file · $0.154 per ML filed
• 2026-07-22 · 8 NDCs, all carried forward from an earlier file · $0.154 per ML filed

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with SODIUM BICARBONATE 8.4% VIAL.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-08-12, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 13 NDCs’ NADAC prices is $0.154 per ML filed.

Of the 38 other products in FDA’s Osmotic Laxative class priced per ML, 5 have a higher middle NADAC price and 33 a lower one. The one in the middle is ANTACID ANTI-GAS LIQUID, at $0.01206 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $12.48 for 50 mL, at an average of $0.24963 per ML in 2024 (2024-01-01 to 2024-12-31) for “Sodium Bicarbonate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 8,519 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 50 mL? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $0.154 to $0.15869 per ML for this product, depending on the NDC.
• How much is in the package I am getting? This page uses 50 mL; your package may hold a different amount.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.